Auro Laboratories Ltd (AURL)

Currency in INR
220.05
-1.45(-0.65%)
Closed·
AURL Scorecard
Full Analysis
Trading at a high earnings multiple
AURL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
220.00228.75
52 wk Range
170.00303.00
Key Statistics
Bid/Ask
221.15 / 224.45
Prev. Close
221.5
Open
224.45
Day's Range
220-228.75
52 wk Range
170-303
Volume
2.22K
Average Volume (3m)
5.84K
1-Year Change
-7.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AURL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Auro Laboratories Ltd Company Profile

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers antihistamine; muscle relaxant; diuretic; iron deficiency; anti-diabetic, including Metformin HCL; anti-fungal, ulcer, malaria, and inflammatory; iodine supplement; analgesics; antacids; potassium and sodium iodide; and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid. In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; 3,4,5 - trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram. It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. The company was incorporated in 1989 and is based in Mumbai, India.

Employees
72
Market
India

Compare AURL to Peers and Sector

Metrics to compare
AURL
Peers
Sector
Relationship
P/E Ratio
140.8x28.8x−0.7x
PEG Ratio
−1.610.160.00
Price/Book
3.2x3.5x2.6x
Price / LTM Sales
8.4x2.4x3.4x
Upside (Analyst Target)
-18.6%37.6%
Fair Value Upside
Unlock1.4%5.3%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.17 / --
Revenue / Forecast
27.74M / --
EPS Revisions
Last 90 days

AURL Income Statement

People Also Watch

172.00
RMPH
-1.88%
40.00
RTUB
-4.05%
84.04
RAJO
-1.44%

FAQ

What Stock Exchange Does Auro Laboratories Trade On?

Auro Laboratories is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Auro Laboratories?

The stock symbol for Auro Laboratories is "AURL."

What Is the Auro Laboratories Market Cap?

As of today, Auro Laboratories market cap is 1.40B.

What Is Auro Laboratories's Earnings Per Share (TTM)?

The Auro Laboratories EPS (TTM) is 1.57.

From a Technical Analysis Perspective, Is AURL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Auro Laboratories Stock Split?

Auro Laboratories has split 0 times.

How Many Employees Does Auro Laboratories Have?

Auro Laboratories has 72 employees.

What is the current trading status of Auro Laboratories (AURL)?

As of 17 Oct 2025, Auro Laboratories (AURL) is trading at a price of 220.05, with a previous close of 221.50. The stock has fluctuated within a day range of 220.00 to 228.75, while its 52-week range spans from 170.00 to 303.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.